Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and CoagulopathyLeo Nicolai, Konstantin Stark, Alexander Leunig et al.|Circulation|2020Cited by 570
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trialAxel Bauer, Uwe Dorwarth, Hannes Gänzer et al.|The Lancet Respiratory Medicine|2021Cited by 104
Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID‐19 from influenza pneumoniaLeo Nicolai, Konstantin Stark, Alexander Leunig et al.|Journal of Thrombosis and Haemostasis|2020Cited by 95
CD40-activated B cells induce anti-tumor immunity<i>in vivo</i>Kerstin Wennhold, Michael von Bergwelt‐Baildon|Oncotarget|2016Cited by 57
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infectionKami Pekayvaz, Leo Nicolai, Alexander Leunig et al.|Nature Communications|2022Cited by 41